Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

THC vs EHC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

THC Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 6–4 Matrix Metrics)

THC Overall Winner 6-Pillar Tally: THC 5 – 1 EHC Matrix Metrics: THC 6 – 4 EHC

As of Nov 20, 2026, Tenet Healthcare Corporation New (THC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). THC carries a Unified Composite Score of 50.3/100 (HOLD) at $263.19 (13.0x Forward P/E, 19.1% operating margin), whereas EHC carries 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin).

  • Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. THC 50.3/100 HOLD), THC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.1% vs. 18.4% operating margin) and revenue trajectory (+6.5% vs. +8.9% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About THC vs EHC
THC NYSE Head-to-Head Winner
Tenet Healthcare Corporation New
Services-General Medical & Surgical Hospitals, Nec
$263.19
-0.15% 1D
Market Cap $21.0B
TTM Revenue $22.2B
Forward P/E 13.0x
Beta / 30D Vol 0.53β · 44% Vol
Unified Composite Score
50.3 / 100 HOLD
Tech 25.0 Fund 46.0 Flow 68.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 41
RSI-14: 40.7 · SMA20: $277.89 · SMA50: $268.88
EHC NYSE
Encompass Health Corporation Common Stock
Services-Hospitals
$133.65
+1.04% 1D
Market Cap $13.0B
TTM Revenue $6.34B
Forward P/E 19.4x
Beta / 30D Vol -0.10β · 40% Vol
Unified Composite Score
52.0 / 100 HOLD
Tech 40.0 Fund 47.0 Flow 54.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 50
RSI-14: 49.8 · SMA20: $135.78 · SMA50: $128.15

6-Pillar Scorecard Institutional Category Breakdown (THC 5 – 1 EHC)

Columns: Metric · THC · EHC
1. Valuation Multiples THC
Forward P/E 13.0x 19.4x
Trailing P/E 7.7x 21.2x
PEG Ratio 1.79x 0.41x
EV / Revenue 1.4x 2.5x
2. Growth & Scale THC
Revenue Growth (YoY) +6.5% +8.9%
Earnings Growth (YoY) +221.5% +21.6%
TTM Revenue (USD) $22.2B $6.34B
Market Cap $21.0B $13.0B
3. Profitability & Quality THC
Gross Margin 42.5% 44.1%
Operating Margin 19.1% 18.4%
Net Profit Margin 13.1% 10.2%
Return on Equity (ROE) 41.7% 25.1%
4. Balance Sheet & Cash Flow THC
Cash Generation (TTM) $3.33B $457M
Cash Flow Margin 15.0% 7.2%
Net Cash / Leverage $10.6B Net Debt (2.43x D/E) $2.73B Net Debt (1.05x D/E)
Dividend Yield None (0.00%) 0.58%
5. Options & Positioning THC
Options Structure Phase CONSOLIDATION CONSOLIDATION
Current IV / %ile 39.9% (4th %ile) 27.0% (8th %ile)
Put/Call OI Skew 0.92x (Balanced) 0.25x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Neutral DISTRIBUTION · Neutral
6. R&D & Supply-Chain Moat EHC
OpEx & R&D Intensity 23.4% of Rev ($5.18B) 25.7% of Rev ($1.63B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: THC (6) vs EHC (4)
Institutional Metric THC EHC Criterion Row Edge
Market Capitalization
Scale
$21.0B $13.0B Larger Scale THC
Trailing P/E Ratio
Valuation
7.7x 21.2x Lower Multiple THC
Forward P/E Ratio
Valuation
13.0x 19.4x Lower Multiple THC
Revenue Growth (YoY)
Growth
+6.5% +8.9% Higher Growth EHC
Operating Margin (TTM)
Profitability
19.1% 18.4% Higher Margin THC
Net Profit Margin
Profitability
13.1% 10.2% Higher Margin THC
Return on Equity (ROE)
Capital Efficiency
41.7% 25.1% Higher ROE THC
52-Week Range Position
Momentum
73% ($158–$301) 80% ($93–$144) Stronger Trend EHC
Beta / 30D Volatility
Risk Regime
0.53β · 44% Vol -0.10β · 40% Vol Lower Realized Risk EHC
Unified Institutional Score
Composite Signal
50.3 / 100 (HOLD) 52.0 / 100 (HOLD) Higher Composite EHC
Trailing 12M Revenue (USD)
Operating Scale
$22.2B $6.34B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
42.5% 44.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.79x PEG · 1.4x EV/Rev 0.41x PEG · 2.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$3.33B ($10.6B Net Debt (2.43x D/E)) $457M ($2.73B Net Debt (1.05x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon EHC +8.81 pp
THC: -2.75% · EHC: +6.06%
3M Horizon EHC +16.06 pp
THC: -5.53% · EHC: +10.53%
6M Horizon THC +24.12 pp
THC: +51.45% · EHC: +27.33%
1Y Horizon THC +16.07 pp
THC: +35.49% · EHC: +19.42%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period THC Revenue EHC Revenue THC Op. Margin EHC Op. Margin Margin Leader
FY2018 $18.3B $4.28B 8.9% 13.0% EHC
FY2019 $18.5B $4.61B 8.3% 13.3% EHC
FY2020 $17.6B $3.57B 11.3% 15.8% EHC
FY2021 $19.5B $4.01B 14.7% 13.9% THC
FY2022 $19.2B $4.35B 12.2% 12.4% EHC
FY2023 $20.6B $4.80B 12.2% 7.3% THC
FY2024 $20.7B $5.37B 28.8% 8.5% THC
FY2025 $21.3B $5.94B 16.5% 9.5% THC

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
THC CONSOLIDATION
64d in phase · OBV DISTRIBUTION
Current IV 39.9%
IV Percentile 4th %ile
Put/Call OI Skew 0.92x (Balanced)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact THC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
EHC CONSOLIDATION
73d in phase · OBV DISTRIBUTION
Current IV 27.0%
IV Percentile 8th %ile
Put/Call OI Skew 0.25x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact EHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $291.54 · IV 37.5%

THC Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($29,154)

Compare $29,154 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 37.5% ATM IV.

5-DAY BULLISH SWING Liq C

Dec 18 $290 / $320 Bull Call Spread

Buy 1x $290C · Sell 1x $320C · 32d

Net Entry $1,123 Debit
T+5d @ +5% Move +$461 (+41%)
Max Risk / Buffer $1,123 Capped
5d Edge & Liquidity 0.8x R:R · Liq C
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $270 / $240 Bull Put Spread

Sell 1x $270P · Buy 1x $240P · 32d

Net Entry $382 Credit
Max Credit / Yield +$382 (+14.6% RoM)
Max Risk / Buffer -8.7% Cushion ($2,618 Mgn)
5d Edge & Liquidity 78% PoP · Liq B
Simulate 5-Day Payoff →
ASYMMETRIC 3-LEG STRUCTURE Liq C

Dec 18 $270P / $290-$320C Seagull

Sell 1x $270P · Buy 1x $290/$320C · 32d

Net Entry $671 Debit
T+5d @ +5% Move +$775 (+16.1% RoM)
Max Risk / Buffer -7.4% Put Cushion ($4,800 Mgn)
5d Edge & Liquidity 0.8x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
THC Moat Profile High-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $21.0B market capitalization and 19.1% operating margin.
OpEx & R&D Reinvestment 23.4% of Rev ($5.18B)
90D Engineering Disclosures 0 Published
EHC Moat Profile Scale & Operating Efficiency Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $13.0B market capitalization and 18.4% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($1.63B)
90D Engineering Disclosures 0 Published

Investor FAQ THC vs EHC Key Questions & Quantitative Answers

As of Nov 20, 2026, Tenet Healthcare Corporation New (THC) is the stronger overall head-to-head candidate over Encompass Health Corporation (EHC) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). THC carries a Unified Composite Score of 50.3/100 (HOLD) at $263.19 (13.0x Forward P/E, 19.1% operating margin), whereas EHC carries 52.0/100 (HOLD) at $133.65 (19.4x Forward P/E, 18.4% operating margin). Composite vs. Pillar Nuance: While EHC currently prints a higher short-term Unified Composite Score (52.0/100 HOLD vs. THC 50.3/100 HOLD), THC captures the overall institutional head-to-head verdict (6–4 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (19.1% vs. 18.4% operating margin) and revenue trajectory (+6.5% vs. +8.9% YoY).

THC leads the Growth & Scale pillar: THC posts +6.5% YoY revenue growth and +221.5% YoY earnings growth on $22.2B TTM revenue (42.5% gross margin, 19.1% operating margin), compared with EHC at +8.9% YoY revenue growth and +21.6% YoY earnings growth on $6.34B TTM revenue (44.1% gross margin, 18.4% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), THC cumulative revenue shifted +16.4% while EHC shifted +38.8%. In operating R&D and SG&A reinvestment, THC deploys 23.4% of Rev ($5.18B) (0 90-day corporate R&D disclosures) versus 25.7% of Rev ($1.63B) (0 disclosures) for EHC.

THC screens cheaper on headline valuation multiples. THC trades at 13.0x Forward P/E, 7.7x Trailing P/E, 1.79x PEG, and 1.4x EV/Revenue (15.0% FCF margin), whereas EHC trades at 19.4x Forward P/E, 21.2x Trailing P/E, 0.41x PEG, and 2.5x EV/Revenue (7.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against THC (41.7% ROE) versus EHC (25.1% ROE) capital efficiency.

In options market volatility and institutional positioning, THC carries 39.9% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.92x (Balanced) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.53β · 44% Vol realized risk). By comparison, EHC carries 27.0% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.25x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.10β · 40% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.